79 related articles for article (PubMed ID: 18681831)
61. Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms.
Jin Y; Liang ZY; Zhou WX; Zhou L
Hepatol Int; 2019 Mar; 13(2):180-189. PubMed ID: 30600477
[TBL] [Abstract][Full Text] [Related]
62. Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α.
Schelter F; Halbgewachs B; Bäumler P; Neu C; Görlach A; Schrötzlmair F; Krüger A
Clin Exp Metastasis; 2011 Feb; 28(2):91-9. PubMed ID: 21053058
[TBL] [Abstract][Full Text] [Related]
63. Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.
Ricca TI; Liang G; Suenaga AP; Han SW; Jones PA; Jasiulionis MG
Transl Oncol; 2009 Dec; 2(4):329-40. PubMed ID: 19956395
[TBL] [Abstract][Full Text] [Related]
64. Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host.
Kopitz C; Anton M; Gansbacher B; Krüger A
Cancer Res; 2005 Oct; 65(19):8608-12. PubMed ID: 16204025
[TBL] [Abstract][Full Text] [Related]
65. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line.
Krüger A; Sanchez-Sweatman OH; Martin DC; Fata JE; Ho AT; Orr FW; Rüther U; Khokha R
Oncogene; 1998 May; 16(18):2419-23. PubMed ID: 9620561
[TBL] [Abstract][Full Text] [Related]
66. Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.
Kopitz C; Gerg M; Bandapalli OR; Ister D; Pennington CJ; Hauser S; Flechsig C; Krell HW; Antolovic D; Brew K; Nagase H; Stangl M; von Weyhern CW; Brücher BL; Brand K; Coussens LM; Edwards DR; Krüger A
Cancer Res; 2007 Sep; 67(18):8615-23. PubMed ID: 17875701
[TBL] [Abstract][Full Text] [Related]
67. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
Elezkurtaj S; Kopitz C; Baker AH; Perez-Cantó A; Arlt MJ; Khokha R; Gansbacher B; Anton M; Brand K; Krüger A
J Gene Med; 2004 Nov; 6(11):1228-37. PubMed ID: 15390257
[TBL] [Abstract][Full Text] [Related]
68. Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator.
Schrötzlmair F; Kopitz C; Halbgewachs B; Lu F; Algül H; Brünner N; Gänsbacher B; Krüger A
J Cell Mol Med; 2010 Dec; 14(12):2760-70. PubMed ID: 19863693
[TBL] [Abstract][Full Text] [Related]
69. Plasminogen activator inhibitor-2, but not cystatin C, inhibits the prometastatic activity of tissue inhibitor of metalloproteinases-1 in the liver.
Kopitz C; Gerg M; Gansbacher B; Krüger A
Hum Gene Ther; 2008 Oct; 19(10):1039-49. PubMed ID: 18681831
[TBL] [Abstract][Full Text] [Related]
70. Premetastatic niche formation in the liver: emerging mechanisms and mouse models.
Krüger A
J Mol Med (Berl); 2015 Nov; 93(11):1193-201. PubMed ID: 26400831
[TBL] [Abstract][Full Text] [Related]
71.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
72.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]